Camber Pharma Launches Generic Strattera®

Piscataway, NJ, May 24, 2021– Camber Pharmaceuticals is pleased to announce that it has launched Atomoxetine Capsules, which is the generic version of Strattera®
Atomoxetine Capsules are used to treat attention-deficit hyperactivity disorder (ADHD).
Atomoxetine Capsules are available from Camber in 10, 18, 25, 40, 60, 80 and 100 mg- 30 count bottles.
Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products. Its parent company, Hetero Drugs of Hyderabad India, is one of the world’s leading API and finished dosage manufacturers. Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.
# # #
If you would like more information about this topic, please contact Megan Little at [email protected].
Recent articles
- 28 New Generics in 2022 and Anticipates Record Number of Approvals in 2023
- Camber Pharmaceuticals Launches Generic Cambia®
- Camber Pharmaceuticals Launches Generic Kuvan® Tablets and Powder for Oral Solution
- Camber Pharmaceuticals Launches Generic Vimpat® Injection
- Camber Pharmaceuticals Launches Generic Naprosyn®
- Camber Pharmaceuticals Launches Generic Lamictal XR®